dipharma_paola, Author at Dipharma

About dipharma_paola

This author has not yet filled in any details.
So far dipharma_paola has created 45 blog entries.

Agile, Integrated, and Clientfocused: the Dipharma Model for Modern CDMO Services

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2025-08-25T13:52:48+00:00August 25th, 2025|

Pharma Tech Outlook interviews Andrea Confetti, Exclusive Synthesis BU Leader

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2025-06-04T16:29:29+00:00June 4th, 2025|

Dipharma at ISPROCHEM 2025 with the Case Study: “The Hunt for NDSRIs”

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2025-05-30T18:45:17+00:00May 30th, 2025|

Dipharma supports the next generation of scientists and fosters scientific passion

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2025-05-30T18:21:24+00:00May 15th, 2025|

Dipharma awarded Bronze Medal by EcoVadis for Sustainability

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2025-04-18T12:54:09+00:00April 18th, 2025|

Pharma Tech Outlook Europe awards Dipharma as “CDMO Solution of the Year in Europe 2025”

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2025-05-12T16:58:27+00:00March 18th, 2025|

Mario Biazzi, Founder of Dipharma Group, and His Contribution to the History of Nitroglycerin

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2025-02-24T14:55:59+00:00February 24th, 2025|

Dipharma’s Vademecum on Safe Handling of Azide Compounds

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2025-05-12T16:55:03+00:00February 21st, 2025|

Dipharma granted first CADIFA by Brazilian ANVISA for the Ursodeoxycholic Acid

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2024-10-15T15:48:58+00:00October 15th, 2024|

CANDESARTAN CILEXETIL

Therapeutic class: Antihypertensive CAS number: 145040-37-5 Regulatory status: EU [...]

dipharma_paola2024-09-23T08:38:37+00:00September 18th, 2024|